Investigational immunotherapy drug shrinks tumors in high-risk neuroblastoma patients

Posted by on June 3, 2016 11:17 am
Categories: health

Investigators report promising preliminary results for an experimental monoclonal antibody when combined with chemotherapy for newly diagnosed neuroblastoma patients.

Leave a Reply

Your email address will not be published. Required fields are marked *